Fair Value Measurements - Narrative (Details) $ in Thousands, £ in Millions |
Dec. 31, 2022
USD ($)
segment
|
Dec. 31, 2022
GBP (£)
segment
|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2022
GBP (£)
|
Oct. 06, 2021
USD ($)
|
---|---|---|---|---|---|
Fair Value, Recurring | |||||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||||
Contingent consideration | $ 16,439 | ||||
Fair Value, Recurring | Interest Rate Swap | |||||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||||
Number of instruments | segment | 2 | 2 | |||
Aidvantage | |||||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||||
Contingent consideration | $ 14,000 | $ 13,800 | |||
BZ Bodies Limited | |||||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||||
Contingent consideration | $ 2,400 | £ 2.0 | $ 2,400 | £ 2.0 | |
Maximum | Navient | |||||
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] | |||||
Contingent consideration | $ 65,000 |
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of derivative instruments of a particular group held by the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|